Top Tech Companies (135)

Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use

Ori Biotech is a London- and New Jersey-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments. By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to...

Ancestry is the global leader in family history and consumer genomics. Every day, around the world, we help curious people like you embark on journeys of personal discovery to enrich lives. With our unparalleled collection of more than 40 billion records from more than 80 countries and 23+ million people in our growing DNA network, Ancestry helps customers discover their family...

QIO Technologies is a sustainability tech company delivering Industrial IoT AI software products supporting energy-intensive and asset-heavy Industrial, Data Center and Telecom companies to reduce greenhouse gas emissions, improve energy efficiency, and accelerate operational sustainability. QiO developed its Foresight Sustainability Suite™ in response to the difficulties faced by industry in leveraging large, disparate sources of operational data to reduce GHG...

CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research...

Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments. Understanding there is no “one size fits all” in engineering ADCs, Pheon takes a methodical approach to ADC development. Using both novel and clinically validated...

BlakBear tells you how fresh your food is. We replace shelf-life on fish and meat with a sensor that actually knows. Founded by scientists from Imperial College, we sell freshness sensors and a cloud API, to improve quality control, add shelf-life and cut food waste from producer to consumer.

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...

Ellipses Pharma is an international drug development company, focused exclusively on the advancement of innovative cancer treatments through the clinic. New treatments for cancer are not progressing fast enough. Ellipses is dedicated to making a difference. Headquartered in London, Ellipses is run by a world class leadership team, overseeing a rapidly growing pipeline of high quality clinical oncology opportunities. Supported...

MultiplAI Health is a preventive medicine company pioneering blood screening for cardiovascular and other complex diseases. Powered by genomic RNAseq, proprietary data transformation, and comprehensive AI analysis, our test transforms a single blood sample into a precision, actionable risk assessment to drive proactive health management that will extend lifespan. We have a laboratory-validated prototype and are conducting our sixth clinical...

Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders

Celebrating 40+ Years! Our MISSION is to assure that new discoveries in cancer drug development have the very best opportunity to be of benefit to mankind with a VISION to improve treatment and make cancer a livable disease.

Tailor Bio is developing an AI-driven drug discovery platform for pan-cancer precision medicine. We're doing this by focussing on Chromosomal Instability, a genomic phenomenon present in 80% of all cancers.

GlamorousAI is bringing drugs to every target though its AI-first SaaS platform for drug discovery, RosalindAI. RosalindAI advancing AI to address small, noisy and sparse data challenges with a technology validated experimentally in the lab.

Our team of scientists and product experts are on a mission: developing Sensory Intelligence to seamlessly anchor machines into physical reality. Exciting things are in the pipeline... Stay tuned! #SensoryIntelligence #FutureOfMachines

Causaly amplifies human cognitive abilities to expand the boundaries of discovery towards making the best decisions in Biomedicine. To achieve this, we are teaching computers to read all knowledge ever published and develop an interface that allows humans to answer questions they can’t ask anywhere else.

We’re a team made up of healthcare workers who’ve lived the struggles of temporary staffing. So we’re here to transform the way it’s managed once and for all, by unleashing the power of flexible working to solve the global healthcare workforce crisis. How do we do it? We combine our industry-leading technology with our extensive specialist expertise - to bring...

Eternal is solving the absence of a properly sustainable and cost-effective protein ingredient that is flavor neutral. The company uses AI and computer vision to improve the fungi fermentation techniques of existing and approved strains. The result is a market-ready product that suits better the needs of a range of food manufacturers, reducing the amount of post processing needed for...

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently...

Founded in 2013, Eleusis is a clinical-stage life science company dedicated to unlocking the full therapeutic potential of psychedelics, guided by science and enabled by drug discovery, clinical development and care delivery design. The company’s comprehensive discovery and development capabilities, together with Andala’s care delivery platform, enable it to target a broad spectrum of unmet needs within psychiatry and beyond...